Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

19.00p
   
  • Change Today:
    -0.25p
  • 52 Week High: 48.10
  • 52 Week Low: 14.10
  • Currency: UK Pounds
  • Shares Issued: 412.15m
  • Volume: 63,196
  • Market Cap: £78.31m
  • Beta: 0.02

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

1 Day Chart (24-12-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -80.5% -69.9%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2.5 2.3
Pr/Book 1.3  
Latest F'cast
Revenue 13.2% 11.9%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.01 (18.62) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.20 (30.90) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 30.80 (24.50) (7.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 34.47 (24.10) (5.21)p n/a n/a n/a n/a 0.0%
31-Dec-25 32.15 (18.85) (2.95)p n/a n/a n/a n/a 0.0%
31-Dec-26 27.80 (13.20) (2.56)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

CREO Company Announcements

Director/PDMR Shareholding 16-Dec-2024 07:00 RNS
Total Voting Rights 31-Oct-2024 16:36 RNS
Director/PDMR Shareholding (Replacement) 24-Oct-2024 15:27 RNS

CREO ShareCast News

Director dealings: Creo Medical chairman raises ... 16-Dec-2024 ShareCast
Creo Medical extends closing date for retail offer 04-Oct-2024 ShareCast
Creo Medical reports year of solid progress 26-Jun-2024 ShareCast

Latest CREO Director Deals

Traded Action Notifier PriceAmountValue
13-Dec-24 Buy Kevin Crofton 17.02p 1,179,000 £200,606.85
24-Oct-24 Buy Richard John Rees 20.02p 76,740 £15,359.51
24-Oct-24 Buy Richard John Rees 20.02p 98,000 £19,614.70

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 19.00p
Change Today -0.25p
% Change -1.30 %
52 Week High 48.10
52 Week Low 14.10
Volume 63,196
Shares Issued 412.15m
Market Cap £78.31m
Beta 0.02

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Price Trend
67.48% below the market average67.48% below the market average67.48% below the market average67.48% below the market average67.48% below the market average
45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average
Income Not Available
Growth
25.27% above the market average25.27% above the market average25.27% above the market average25.27% above the market average25.27% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 24-Dec-2024

Time Volume / Share Price
12:07 8 @ 19.44p
11:33 10,813 @ 18.81p
11:21 3,000 @ 19.17p
11:09 10,000 @ 18.77p
10:21 100 @ 19.50p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page